Long-term PPI Use May Lead to Nutrient Deficiencies, Caution Advised

Long-term PPI Use Linked to Nutrient Deficiency Risk

The Cliff News | October 5, 2026. Proton Pump Inhibitors (PPIs), commonly used to manage excess stomach acid, may increase the risk of deficiencies in certain essential nutrients with prolonged or excessive use.

Drugs like omeprazole, pantoprazole, esomeprazole, rabeprazole, and lansoprazole are prescribed for conditions such as gastric acidity, Gastro-Esophageal Reflux Disease (GERD), and peptic ulcers by reducing stomach acid production.

While this reduction in acid is therapeutically beneficial, it also plays a crucial role in releasing and absorbing certain nutrients from food. Although typically safe when used under medical supervision and for valid reasons, awareness of potential impacts on nutrient absorption during long-term use is essential.

It is important to note that nutrient deficiencies do not necessarily occur in every PPI user, but the risk may be elevated for individuals on these medications for extended periods.

Impact on Vitamin B12 Absorption

Vitamin B12 absorption is significantly influenced by gastric acid. Stomach acid is required to convert dietary vitamin B12 into a form the body can absorb. When stomach acid production is consistently low, vitamin B12 absorption can be compromised.

Deficiency symptoms can include anemia, extreme weakness, fatigue, tingling in the hands and feet (neuropathy), and in severe cases, cognitive impairment.

Increased Risk of Magnesium Deficiency

Another significant, though less common, concern with long-term PPI use is magnesium deficiency. Absorption of magnesium by the intestines may be hindered, particularly in sensitive individuals.

If magnesium deficiency becomes severe, symptoms can include muscle cramps, tremors, physical weakness, and irregular heartbeats. These symptoms should never be ignored, and immediate medical advice should be sought.

Effect on Iron Absorption

Reduced stomach acid can also affect the absorption of iron. Non-heme iron, primarily from plant-based foods, relies heavily on stomach acid for absorption. Some individuals on chronic PPI therapy may face an increased risk of iron deficiency and associated anemia.

Prompt medical evaluation is crucial if symptoms like persistent fatigue, weakness, dizziness, or pale skin appear. Immediate medical attention is essential.

Potential Impact on Calcium and Bone Health

The situation with calcium is somewhat more complex. Reduced stomach acid can impair the absorption of certain calcium salts, such as calcium carbonate. Several studies have indicated a link between prolonged PPI use and an increased risk of bone fractures.

However, this association does not mean every PPI user will develop calcium deficiency or osteoporosis. Age, nutritional status, physical activity levels, and other existing illnesses also significantly impact bone health.

Limited Evidence on Other Nutrients

Potential effects on other nutrients like vitamin D, folate, and zinc have been discussed, but the evidence is less clear compared to vitamin B12 or magnesium. Vitamin D deficiency can affect calcium metabolism and bone strength, while folate deficiency can lead to megaloblastic anemia.

Zinc deficiency can cause delayed wound healing, altered taste, and immune system issues, but evidence linking PPIs to zinc deficiency remains limited.

Regular Check-ups and Proper Management

For individuals taking PPIs continuously for months or years, especially the elderly or those at high risk of anemia, osteoporosis, neuropathy, muscle cramps, or malnutrition, doctors may recommend laboratory tests as needed.

These can include CBC, serum ferritin, iron/TIBC, vitamin B12, and serum magnesium. Depending on the circumstances, tests for 25-OH vitamin D and levels of calcium, phosphate, or PTH might also be performed.

Balanced Use is Key

PPI medications should not be stopped abruptly solely due to concerns about nutrient deficiencies. Suddenly discontinuing the medication can exacerbate acidity or reflux symptoms in some individuals.

The safest approach is to review the ongoing need for the medication, its appropriate dosage, and the total duration of treatment with a doctor. If long-term PPI use is not necessary, gradual dose reduction or discontinuation can be considered under medical guidance.

Judicious use of PPIs, with proper indications, prescribed duration, and continuous medical monitoring, can still prove highly beneficial for many patients.